ACHC Acadia Healthcare Company, Inc.

XNAS 38.55 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

ACHC $38.55 —
Key stats
$38.55
52-Week Range
$11.43 – $39.70
YTD
+169.77%
IV Rank (30D)
14.94
Straddle Price
$4.72
P/C Vol Ratio
0.21
Market Cap
$3.4B
Open
$37.91
Day Range
$37.79 – $39.70
Volume
1,421,163
Prev Close
$37.00
Fair Value
MODEL: NEUTRAL

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.90%
Beta vs SPY0.73
Cost of Equity (CAPM)8.53% (VRP-adj)
WACC7.07%
Volatility Risk Premium+99.2pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)-4.7%
DCF Horizon5 years explicit + fade
Free Cash Flow (TTM)$-0.1B
Return on Equity (TTM)-56.9%
Book / Price58.3% — banking bias active (P/B is primary)
Gross Margin (TTM)100.0%
FCF Margin (TTM)-4.0%
Debt / Equity1.27
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$29.40 (Market Anchor value)
SMA 20 / Bollinger Mid$31.14
Bollinger Width / SMA2023.6% (drives anchor stability)
Net Debt$2.3B
Market Cap$3B
Peers used for multiples: ACAD, DFTX, LFST, MPLT, SUPN, UNH (filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
23%
20-Day Fair Value
≈ by Dec 8, 2026
$38.19
α -1.2% rank 94%
conviction
75%
40-Day Fair Value
≈ by Jan 6, 2027
$39.42
α +1.9% rank 94%
conviction
62%
60-Day Fair Value
≈ by Feb 4, 2027
$38.35
α -0.8% rank 94%
conviction
23%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 25.1× · 3 peers
Peer EV/EBITDA $140.31 13% median 25.7× · 4 peers
Peer P/B $67.46 17% median 3.1× · 6 peers
Peer P/S $94.61 17% median 2.5× · 4 peers
Market Anchor (SMA50) $29.40 54% stability 63% (BB-width)
Options Expected (B-L 30d) $37.40 0% 6 strikes · skew +0.14
As of 2026-11-09 · updated
About
Industry (SIC)
SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC (8093) · industry map
Exchange
XNAS
Market Cap
$3.4B
Employees
25,000
List Date
2011-11-01
CIK
0001520697
Last Earnings
Nov 4 after close · +7.9% vs ±16.2% expected
Next Earnings
~Feb 24, 2027 (estimated)
Headquarters
Franklin, TN
Homepage
https://www.acadiahealthcare.com

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan0.38%-12.66%3.12%4.96%10.65%-5.95%0.08%
Feb4.25%6.92%-13.74%2.05%-33.08%77.44%7.31%
Mar1.96%8.06%-2.77%-5.68%3.62%-0.21%0.83%
Apr7.25%1.04%-0.36%-2.80%-21.82%9.40%-1.22%
May3.66%6.43%0.17%-5.62%-0.61%-16.70%-2.11%
Jun-2.86%-1.89%12.37%-1.42%4.90%26.68%6.30%
Jul-2.86%15.83%-0.20%-3.22%-7.32%-4.90%-0.45%
Aug7.09%0.00%-1.76%10.58%8.87%-9.91%2.48%
Sep-4.28%-3.87%-9.28%-18.92%5.59%-2.65%-5.57%
Oct-5.33%0.31%5.65%-31.60%-12.42%11.25%-5.36%
Nov-11.12%10.98%-0.65%-3.31%-19.29%30.42%*1.17%
Dec12.91%-6.05%5.28%-6.75%-15.74%---2.07%
Total9.01%23.99%-4.66%-51.11%-60.31%132.65%8.26%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $31.57
SMA 50: $29.61
SMA 200: $26.39
Current: $38.64
EMA 12: $33.01
EMA 26: $31.46
MACD: 1.5536 | Signal: 0.7756
BULLISH
ADX (14): 25.52
TREND
+DI: 40.73
−DI: 8.05

Momentum Oscillators

RSI (14): 79.23
OVERBOUGHT
Stoch %K: 74.60
Stoch %D: 62.77
Williams %R: -9.81

Volume & Volatility

BB Upper: $36.44
BB Lower: $26.70
OVERBOUGHT
OBV: 130,089,319
Vol SMA 20: 2,171,365
Vol ROC: 3.09%
ATR: $2.04
True Range: $2.70
HV 20: 56.6%
HV 30: 50.5%
HV 60: 49.5%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Written before ACHC’s Nov 4 earnings report, so it doesn’t reflect the results.

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 6/10)

Key drivers: Strong technical signals, positive news sentiment, and low volatility.

Primary risks: Divergence between technical indicators and news sentiment, potential for mean reversion.

Investment thesis: ACHC is a healthcare services stock with a strong fundamental profile, supported by favorable technical trends. The stock has been trading within a consolidation range, with recent news headlines highlighting the industry's growth prospects. Our analysis suggests that ACHC could break out to the upside in the near term, driven by improved sentiment and reduced volatility.

Recent news sentiment impact: Positive sentiment from recent news headlines, particularly those related to the behavioral health market, has contributed to the stock's upward momentum.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): Uptrend, Medium-term (1-3 months): Consolidation range, Long-term (3-12 months): Uptrend

Support/Resistance Levels: Key price levels include:

  • SMA 20: $25.85
  • SMA 50: $25.36
  • Upper Bollinger Band: $28.92

Momentum Signals: RSI interpretation: Neutral, as the RSI reading of 38.2% is within the neutral range. MACD signal: Bearish, with the MACD histogram at -0.05 indicating a bearish momentum signal. Bollinger Bands position: Neutral, as the price action is situated between the middle and upper bands.

Volume Analysis: Volume trends suggest institutional interest, with volume rates of change above 40%.

News & Sentiment Analysis

Recent Headlines Summary: Positive news headlines from the behavioral health market have contributed to the stock's upward momentum. Recent stories highlight industry growth prospects and favorable trends.

Sentiment Assessment: Positive sentiment dominates recent news headlines (4 out of 6 articles have positive sentiment).

Catalyst Identification: Upcoming catalysts include earnings reports, product launches, and potential partnerships in the behavioral health market.

Risk & Volatility Assessment

Beta Interpretation: Low risk, as the stock's beta is relatively low at 0.59 compared to the SPY (S&P 500).

Volatility Regime: Current volatility levels are lower than historical averages, indicating a low-volatility regime.

Options Market Signals: IV rank: Medium, with an IV of 141.0%. Unusual activity suggests institutional interest in options trading.

Downside Protection: Support levels include the SMA 20 and SMA 50, providing some protection against potential downside movements.

Market Context & Positioning

Sector Performance: ACHC is outperforming its sector peers, indicating a favorable market positioning.

Institutional Activity: Institutional interest in options trading suggests that investors are positioning themselves for potential upside moves.

Correlation Analysis: ACHC's correlation with the SPY is relatively low at 0.11, indicating some independence from broader market trends.

Key Levels & Action Items

Critical Price Levels:

  • SMA 20: $25.85 (support)
  • Upper Bollinger Band: $28.92 (resistance)

Breakout/Breakdown Levels:

  • Breakout above the upper Bollinger Band could trigger a significant move to the upside.
  • Breakdown below the SMA 20 could indicate a reversal of the uptrend.

Time-Sensitive Catalysts: Upcoming earnings reports and product launches could provide near-term catalysts for price movements.

Risk Management: Stop-loss levels should be set at the SMA 20, with position sizing considerations based on individual risk tolerance.

Generated
News
All ACHC news →
Earnings History
18 of 25 under expected move
Avg Expected Move
11.37%
Avg Actual Move
7.54%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-02-26 After-Close 10.99% 1.45% 0.13x Within
2021-04-29 After-Close 4.40% 0.80% 0.18x Within
2021-08-02 After-Close 10.77% 3.05% 0.28x Within
2021-10-28 After-Close 6.56% 6.20% 0.95x Within
2022-02-28 After-Close 7.49% 6.93% 0.93x Within
2022-05-03 After-Close 8.97% 7.07% 0.79x Within
2022-07-27 After-Close 8.74% 4.06% 0.46x Within
2022-10-31 After-Close 9.10% 1.29% 0.14x Within
2023-02-27 After-Close 7.34% 9.91% 1.35x Exceeded
2023-04-26 After-Close 5.53% 1.74% 0.31x Within
2023-07-27 After-Close 6.72% 8.26% 1.23x Exceeded
2023-11-02 After-Close 7.03% 1.37% 0.19x Within
2024-02-27 After-Close 7.63% 4.52% 0.59x Within
2024-05-01 After-Close 7.06% 8.58% 1.22x Exceeded
2024-07-31 After-Close 12.41% 14.25% 1.15x Exceeded
2024-10-30 After-Close 17.95% 18.03% 1.00x Exceeded
2025-01-13 After-Close 5.23% 2.29% 0.44x Within
2025-02-27 After-Close 19.44% 25.53% 1.31x Exceeded
2025-05-12 After-Close 15.67% 4.26% 0.27x Within
2025-08-05 After-Close 15.85% 17.28% 1.09x Exceeded
2025-11-05 After-Close 25.15% 2.03% 0.08x Within
2026-02-25 After-Close 14.40% 6.96% 0.48x Within
2026-04-29 After-Close 15.92% 8.37% 0.53x Within
2026-07-28 After-Close 17.82% 16.34% 0.92x Within
2026-11-04 After-Close 16.20% 7.88% 0.49x Within

Earnings calendar: this week’s reports with expected vs actual moves →

ACHC Options Activity & IV Rank

ACHC IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 46.4%
7-DTE IV: 56.6%
Expected Move: $4.72
7-DTE Move: $3.27
Days to Exp: 39 (2026-12-18)

Options Flow · All expiries

Call Volume: 2,667
Put Volume: 558
P/C Volume: 0.209
BULLISH
Call OI: 10,974
Put OI: 4,175
P/C OI: 0.38
Total OI: 15,149

ATM Options Pricing

ATM Call: $1.73
ATM Put: $3.00
Call %: 4.5%
Put %: 7.8%

Chain Summary

Chain Volume: 3,225
Chain OI: 15,149
Last Updated: 11/9/2026
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 88th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
88%
vs own history
GEX tilt
+0.95
OI-weighted, today
Vanna tilt
-0.41
δ-sensitivity to IV
Charm tilt
-0.02
δ-decay vs time
Vanna tilt -0.41: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably if implied volatility changed.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 10 ATM contracts, 4k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
No data
30 DTE / 10d —
— pts EXTREME
No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)12.4LowNov 9
IV Rank (30 DTE)14.9LowNov 9
Straddle Price (30 DTE)$4.72Nov 9
Beta Analysis

Risk Metrics

Beta: 0.6687
Alpha: 81.56%
Correlation: 0.1398
R-Squared: 2.0%
Stock Volatility: 65.8%
Market Volatility: 13.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own ACHC
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$78.7M
0.05%
#494 of 6285-1.9%13F
Bridgewater Associates Hedge fund
Ray Dalio
$1.9M
0.01%
#727 of 997new13F
Rockefeller Capital Management Family office
Rockefeller family
$765K
0.00%
#1860 of 4729-8.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

ACHC Institutional Ownership (13F)

Filings for 2026-06-30 · 115 already for 2026-09-30
Diluted shares outstanding: 90,645,750 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

311 filers135,572,822 shares$3.96B value149.56% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 14,957,168 $441.69M 11.14% 16.50% 2026-06-30
2 Wellington Management Group LLP Custodian 5,726,246 $169.10M 4.27% 6.32% 2026-06-30
3 Vanguard Portfolio Management LLC 5,369,461 $158.56M 4.00% 5.92% 2026-06-30
4 FMR LLC Custodian 5,015,727 $148.11M 3.74% 5.53% 2026-06-30
5 CARRONADE CAPITAL MANAGEMENT, LP 4,762,635 $140.64M 3.55% 5.25% 2026-06-30
6 Morgan Stanley Custodian 4,534,269 $133.90M 3.38% 5.00% 2026-06-30
7 DEERFIELD MANAGEMENT COMPANY, L.P. 4,520,000 $133.48M 3.37% 4.99% 2026-06-30
8 DME Capital Management, LP 4,400,641 $129.95M 3.28% 4.85% 2026-06-30
9 Dimensional Fund Advisors LP Custodian 4,698,457 $129.21M 3.26% 5.18% 2026-09-30
10 FARALLON CAPITAL MANAGEMENT, L.L.C. 4,220,800 $124.64M 3.14% 4.66% 2026-06-30
11 ABRAMS BISON INVESTMENTS, LLC 4,165,000 $122.99M 3.10% 4.59% 2026-06-30
12 UBS Group AG Custodian 4,044,500 $119.43M 3.01% 4.46% 2026-06-30
13 Vanguard Capital Management LLC 4,010,582 $118.43M 2.99% 4.42% 2026-06-30
14 State Street Corp 3,893,124 $114.81M 2.90% 4.29% 2026-06-30
15 Jefferies Financial Group Inc. 3,703,240 $101.84M 2.57% 4.09% 2026-09-30
16 American Century Companies, Inc. 2,908,887 $85.90M 2.17% 3.21% 2026-06-30
17 Goldman Sachs Group Inc Custodian 2,872,128 $84.81M 2.14% 3.17% 2026-06-30
18 Citadel Advisors LLC Custodian 2,665,603 $78.72M 1.99% 2.94% 2026-06-30
19 MAK CAPITAL ONE LLC 2,432,962 $71.85M 1.81% 2.68% 2026-06-30
20 Geode Capital Management, LLC Custodian 2,413,963 $66.40M 1.67% 2.66% 2026-09-30
21 Neuberger Berman Group LLC 2,238,423 $65.80M 1.66% 2.47% 2026-06-30
22 Charles Schwab Investment Management, Inc. 2,062,966 $60.92M 1.54% 2.28% 2026-06-30
23 VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,807,697 $53.38M 1.35% 1.99% 2026-06-30
24 Invesco Ltd. Custodian 1,790,454 $52.87M 1.33% 1.98% 2026-06-30
25 P2 Capital Partners, LLC 1,774,484 $52.40M 1.32% 1.96% 2026-06-30
10 filers$25.43M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $14.27M 56.12% 2026-06-30
2 Walleye Trading LLC $2.03M 7.98% 2026-06-30
3 PEAK6 LLC $1.96M 7.72% 2026-06-30
4 Jane Street Group, LLC Custodian $1.64M 6.47% 2026-06-30
5 Citadel Advisors LLC Custodian $1.58M 6.22% 2026-06-30
6 GROUP ONE TRADING LLC Custodian $1.21M 4.75% 2026-06-30
7 IMC-Chicago, LLC Custodian $979.00K 3.85% 2026-09-30
8 Simplex Trading, LLC Custodian $869.00K 3.42% 2026-09-30
9 Point72 Asset Management, L.P. $578.79K 2.28% 2026-06-30
10 Walleye Capital LLC $304.16K 1.20% 2026-06-30
10 filers$19.29M notional
# Filer Notional Value % of Total Period
1 JPMorgan Chase & Co Custodian $6.92M 35.89% 2026-06-30
2 Susquehanna International Group, LLP Custodian $5.00M 25.94% 2026-06-30
3 Citadel Advisors LLC Custodian $2.77M 14.38% 2026-06-30
4 Jane Street Group, LLC Custodian $1.84M 9.55% 2026-06-30
5 Point72 Asset Management, L.P. $1.06M 5.51% 2026-06-30
6 Simplex Trading, LLC Custodian $830.50K 4.31% 2026-09-30
7 GROUP ONE TRADING LLC Custodian $354.36K 1.84% 2026-06-30
8 IMC-Chicago, LLC Custodian $346.50K 1.80% 2026-09-30
9 Walleye Capital LLC $121.07K 0.63% 2026-06-30
10 Walleye Trading LLC $29.53K 0.15% 2026-06-30

ACHC Insider Trading (Form 4)

Latest: 2026-07-27
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-27 Brian Farley EVP, CLAO and Secretary Tax (F) −1,770 $34.51 -$61.1K EDGAR
2026-06-26 Brian Farley EVP, CLAO and Secretary Tax (F) −1,370 $26.24 -$35.9K EDGAR
2026-05-08 E. Perot Bissell Director Award (A) +11,831 — EDGAR
2026-05-08 Reeve B Waud Director Award (A) +15,907 — EDGAR
2026-05-08 Patrice A Harris Director Award (A) +6,331 — EDGAR
2026-05-08 Daniel J Cancelmi Director Award (A) +6,331 — EDGAR
2026-05-08 William Grieco Director Award (A) +6,331 — EDGAR
2026-05-08 Jason Bernhard Director Award (A) +11,455 — EDGAR
2026-05-08 Vicky B Gregg Director Award (A) +6,331 — EDGAR
2026-05-08 Ralph David Kelly Director Award (A) +6,331 — EDGAR
2026-05-08 Michael Fucci Director Award (A) +6,331 — EDGAR
2026-05-06 Brian Farley EVP, CLAO and Secretary Tax (F) −5,063 $27.69 -$140.2K EDGAR
2026-04-30 Brian Farley EVP, CLAO and Secretary Award (A) +37,510 — EDGAR
2026-04-13 Brian Farley EVP, GC and Secretary Award (A) +37,510 — EDGAR
2026-04-13 Todd S. Young Chief Financial Officer Award (A) +58,799 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

ACHC Insider Holdings

16 insiders · @ $38.64
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Reeve B Waud Director 728,874 $28.16M -$640.64M 41 2026-05-08
2 Debra K Osteen Chief Executive Officer 710,833 $27.47M -$3.91M 13 2026-01-21
3 Christopher H. Hunter Chief Executive Officer 258,530 $9.99M $0 13 2025-06-27
4 Brian Farley EVP, CLAO and Secretary 135,982 $5.25M $0 14 2026-07-27
5 Heather Brianne Dixon Chief Financial Officer 118,581 $4.58M $0 8 2025-07-29
6 Todd S. Young Chief Financial Officer 107,244 $4.14M $0 2 2026-04-13
7 William Grieco Director 96,212 $3.72M -$2.70M 38 2026-05-08
8 Wade D Miquelon Director 55,520 $2.15M -$188.1K 15 2025-05-30
9 Nasser Khan Chief Operating Officer 55,023 $2.13M $0 4 2025-10-01
10 E. Perot Bissell Director 51,986 $2.01M $0 13 2026-05-08
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

ACHC Board & Officers

As of SEC filings through Jul 27, 2026

Directors 11

Officers 2

  • Debra K Osteen · Chief Executive Officer · listed since Jan 2026
  • Brian Farley · EVP, CLAO and Secretary · listed since Apr 2026
Changes in the last 10 years (37)
Apr 30, 2026Brian Farley listed as EVP, CLAO and Secretary (previously EVP, GC and Secretary) in SEC filings
Apr 23, 2026The company announced the departure of Todd S. Young as Chief Financial Officer in an SEC filing
Mar 12, 2026Daniel J Cancelmi became a director
Mar 9, 2026The company announced the departure of Wade D Miquelon from the board in an SEC filing
Jan 21, 2026Debra K Osteen first listed as Chief Executive Officer in an SEC filing
Jan 20, 2026The company announced the departure of Christopher H. Hunter as Chief Executive Officer in an SEC filing
Oct 30, 2025The company announced the departure of Nasser Khan as Chief Operating Officer in an SEC filing
Oct 27, 2025Todd S. Young became Chief Financial Officer
Aug 16, 2025Timothy August Sides became Interim CFO
Aug 4, 2025The company announced the departure of Heather Brianne Dixon as Chief Financial Officer in an SEC filing
Jun 30, 2024Nasser Khan became Chief Operating Officer
Mar 23, 2024The company announced the departure of John S. Hollinsworth as EVP of Operations in an SEC filing
Oct 26, 2023Patrice A Harris became a director
Jul 26, 2023Brian Farley became EVP, GC and Secretary
Jul 10, 2023Heather Brianne Dixon became Chief Financial Officer
Jun 28, 2023The company announced the departure of Christopher L Howard as EVP, GC and Secretary in an SEC filing
Jun 1, 2023The company announced the departure of Laurence L. Harrod as EVP of Finance in an SEC filing
Jun 1, 2023The company announced the departure of David M. Duckworth as Chief Financial Officer in an SEC filing
Jun 28, 2022Ralph David Kelly became a director
May 20, 2022Debra K Osteen no longer listed as Chief Executive Officer in SEC filings
Not reported recently (10)
  • Timothy August Sides · Last reported as Interim CFO in an SEC filing dated Aug 25, 2025
  • William M Petrie · Last reported as a director in an SEC filing dated Aug 2, 2022
  • Ronald Morgan Fincher · Last reported as Chief Operating Officer in an SEC filing dated May 6, 2019
  • Joey A Jacobs · Last reported as a director in an SEC filing dated Mar 8, 2019
  • Brent Turner · Last reported as President in an SEC filing dated Mar 5, 2019
  • Christopher R Gordon · Last reported as a director in an SEC filing dated May 7, 2018
  • Randall P Goldberg · Last reported as VP of Business Development in an SEC filing dated Mar 16, 2018
  • Bruce A Shear · Last reported as Executive Vice Chairman in an SEC filing dated Feb 7, 2018
  • Scott Schwieger · Last reported as Chief Compliance Officer in an SEC filing dated Aug 2, 2017
  • Hartley R. Rogers · Last reported as a director in an SEC filing dated May 26, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

ACHC Proposed Insider Sales (Form 144)

Latest: 2024-08-30
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2024-08-30 Hollinsworth John S. Officer 20,000 $1.06M 2024-08-30 Merrill Lynch — EDGAR
2024-08-29 Hollinsworth John S. Officer 10,000 $812.1K 2024-08-29 Merrill Lynch — EDGAR
2024-08-08 Hollinsworth John S. Officer 5,000 $357.8K 2024-08-08 Merrill Lynch — EDGAR
2024-03-08 Miquelon Wade D Director 2,203 $188.0K 2024-03-05 Raymond James & Associates, Inc. — EDGAR
2024-03-04 Gregg Vicky B Officer 2,500 $213.8K 2024-03-04 Merrill Lynch — EDGAR
2023-11-15 Hollinsworth John S. Officer 47,500 $3.53M 2023-11-15 Merrill Lynch/Chris Mitchell — EDGAR
2023-11-14 Hollinsworth John S. Officer 45,000 $3.32M 2023-11-14 Merrill Lynch/Chris Mitchell — EDGAR
2023-11-13 144/A Hollinsworth John S. Officer 20,000 $1.46M 2023-11-10 Merrill Lynch/Chris Mitchell — EDGAR
2023-11-13 144/A Hollinsworth John S. Officer 12,500 $931.2K 2023-11-08 Merrill Lynch/Chris Mitchell — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-04
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-11-04 Earnings results · Regulation FD disclosure EDGAR
2026-09-25 Other events EDGAR
2026-07-28 Earnings results · Regulation FD disclosure EDGAR
2026-05-18 Other events EDGAR
2026-05-06 Shareholder vote results EDGAR
2026-04-29 Earnings results · Regulation FD disclosure EDGAR
2026-04-23 Director or officer change · Regulation FD disclosure EDGAR
2026-03-12 Director or officer change · Regulation FD disclosure EDGAR
2026-02-25 Earnings results · Regulation FD disclosure EDGAR
2026-01-23 Director or officer change EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-27 0001193125-26-078266 EDGAR
2025-02-27 0000950170-25-029095 EDGAR
2024-02-28 0000950170-24-022057 EDGAR
2023-02-28 0001564590-23-002737 EDGAR
2022-03-01 0001564590-22-007930 EDGAR
2021-02-26 0001564590-21-009466 EDGAR
2020-02-28 0001564590-20-007769 EDGAR
2019-03-01 0001564590-19-005750 EDGAR
2018-02-27 0001193125-18-061152 EDGAR
2017-02-24 0001193125-17-056016 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-04 0001193125-26-447412 EDGAR
2026-07-28 0001193125-26-321076 EDGAR
2026-04-30 0001193125-26-192508 EDGAR
2025-11-05 0001193125-25-267062 EDGAR
2025-08-05 0000950170-25-103160 EDGAR
2025-05-12 0000950170-25-069294 EDGAR
2024-10-30 0000950170-24-119044 EDGAR
2024-08-01 0000950170-24-089248 EDGAR
2024-05-02 0000950170-24-052085 EDGAR
2023-11-03 0000950170-23-058814 EDGAR
ETF Holders
90 ETFs hold ACHC
25 shown · $920.27M total exposure · 0.19% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IJR iShares Core S&P Small-Cap ETF iShares (BlackRock) 0.20% $208.4M $103.8B 2026-11-06
2 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.12% $90.3M $76.6B 2026-11-06
3 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $82.1M — 2026-09-30
4 AVUV Avantis U.S. Small Cap Value ETF Avantis 0.22% $70.7M $31.6B 2026-11-05
5 DFSV Dimensional US Small Cap Value ETF Dimensional 0.23% $61.1M — 2026-11-05
6 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.03% $57.7M — 2026-09-30
7 DFAT Dimensional US Targeted Value ETF Dimensional 0.15% $46.7M — 2026-11-05
8 VBR Vanguard Morningstar Small-Cap Value ETF Vanguard 0.06% $37.5M — 2026-09-30
9 IWN iShares Russell 2000 Value ETF iShares (BlackRock) 0.24% $33.1M $13.9B 2026-11-06
10 SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF SPDR (State Street) 0.19% $29.5M $15.7B 2026-11-05
11 VXF Vanguard Extended Market ETF Vanguard 0.03% $28.9M — 2026-09-30
12 IJS iShares S&P Small-Cap 600 Value ETF iShares (BlackRock) 0.38% $28.6M $7.5B 2026-11-06
13 FNDA Schwab Fundamental U.S. Small Company ETF Nport 0.29% $26.0M — 2026-08-31
14 SLYV State Street® SPDR® S&P 600™ Small Cap Value ETF SPDR (State Street) 0.36% $17.7M $4.9B 2026-11-05
15 VTWO Vanguard Russell 2000 ETF Vanguard 0.09% $15.1M — 2026-09-30
16 DFAS Dimensional US Small Cap ETF Dimensional 0.04% $14.8M — 2026-11-05
17 SCHA Schwab U.S. Small-Cap ETF Nport 0.05% $12.0M — 2026-08-31
18 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.01% $11.1M — 2026-11-05
19 VIOO Vanguard S&P Small-Cap 600 ETF Vanguard 0.15% $9.1M — 2026-09-30
20 DFMC Dimensional US Micro Cap ETF Dimensional 0.11% $8.3M — 2026-11-05
21 VHT Vanguard Health Care ETF Vanguard 0.03% $6.8M — 2026-09-30
22 AVSC Avantis U.S. Small Cap Equity ETF Avantis 0.21% $6.7M $3.2B 2026-11-05
23 IHF iShares U.S. Healthcare Providers ETF iShares (BlackRock) 0.43% $6.5M $1.5B 2026-11-06
24 RZV Invesco S&P SmallCap 600 Pure Value ETF Invesco 2.23% $6.3M — 2026-11-05
25 RWJ Invesco S&P SmallCap 600 Revenue ETF Invesco 0.26% $5.4M — 2026-11-05
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-12.20
TTM Revenue
$3.37B
TTM Net Income
$-1.11B
TTM Op. Cash Flow
$181.95M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q1 '262026-03-31$828.80M$4.11M$0.05$61.53M
Q4 '252025-12-31$821.46M$-1.18B$-12.98$-86.29M
Q3 '252025-09-30$851.57M$36.25M$0.40$73.21M
Q2 '252025-06-30$869.23M$30.13M$0.33$133.50M
Q1 '252025-03-31$770.50M$8.37M$0.09$11.48M
Q4 '242024-12-31$774.24M$32.62M$0.36$116.70M
Q3 '242024-09-30$815.63M$68.13M$0.74$163.13M
Q2 '242024-06-30$796.04M$78.48M$0.85$171.15M
Q1 '242024-03-31$768.05M$76.38M$0.83$-321.29M
Q4 '232023-12-31$742.80M$57.73M$0.63$116.30M
Q3 '232023-09-30$750.33M$-217.71M$-2.39$137.86M
Q2 '232023-06-30$731.34M$72.30M$0.79$163.77M
Q1 2026 • period ending 2026-03-31 • filed 2026-04-30
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.79
P/S
1.04
EV/EBITDA
9.93
EV/Sales
1.73
ROE
-56.5%
ROA
-20.0%
Div Yield
0.00%
FCF Yield
5.20%
Debt/Equity
1.27
Current Ratio
—
Market Cap
$3.50B
as of 2026-11-09

ACHC vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
ABBV ABBVIE INC. $514.9B 50.5 +10.7% +27.9% 34
UNH UNITEDHEALTH GROUP INCORPORATED (Delawar $353.2B 30.0 +9.7% +18.0% 45
BTSG BrightSpring Health Services, Inc. Commo $13.4B 48.7 +28.0% +78.8% 26
LFST LifeStance Health Group, Inc. Common Sto $5.2B 77.7 +22.6% +112.1% 2
DFTX Definium Therapeutics, Inc. Common Share $4.5B — — +128.3% 24
ACAD Acadia Pharmaceuticals Inc. $3.7B 7.8 +11.8% −33.7% 26
ACHC Acadia Healthcare Company, Inc. $3.4B — +6.8% +170.4% 15
SUPN Supernus, Inc. Common Stock $1.5B — +26.9% −44.2% 10
MPLT MapLight Therapeutics, Inc. Common Stock $385M — — −55.9% 15
Peer median $4.9B 48.7 +17.2% +23.0% 25

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
20.94M
SI % of Float
22.96%
Days to Cover
13.70
Short Vol Ratio
60.9%
Free Float
91.18M
Float %
97.9%
Short interest 2026-10-15 • Short volume 2026-11-06 • Float 2026-08-16